Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitorsEmiliano Calvo, José BaselgaCurrent Oncology Reports|February 19, 2005
Clinical experience with monoclonal antibodies to epidermal growth factor receptorEmiliano Calvo, Eric K RowinskyCancer Cell|August 5, 2020
Clinical Challenges of Immune Checkpoint InhibitorsMaria de Miguel, Emiliano CalvoSeminars in Oncology|August 8, 2006
Novel agents that target tublin and related elementsEric K Rowinsky, Emiliano CalvoCurrent Oncology Reports|February 19, 2005
Approaches to optimize the use of monoclonal antibodies to epidermal growth factor receptorEmiliano Calvo, Eric K RowinskyCancer Cell|November 9, 2021
T cell engagers in solid tumors kick the door downMaria de Miguel, Emiliano CalvoCancer Treatment Reviews|March 18, 2022
First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid featuresMário Fontes-Sousa, Emiliano CalvoClinical Lung Cancer|January 11, 2005
Effect of epidermal growth factor receptor mutations on the response to epidermal growth factor receptor tyrosine kinase inhibitors: target-based populations for target-based drugsEmiliano Calvo, Eric K RowinskyAnti-Cancer Drugs|December 22, 2010
Non-clear cell advanced kidney cancer: is there a gold standard?Pedro Sánchez, Emiliano Calvo, Ignacio DuránThe Lancet Regional Health. Europe|May 8, 2026
Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunityAndré Mansinho, Joana Albuquerque, Emiliano CalvoPageof 16